Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Patient care should come before profit in medicine.

Certain cancer drugs can cause skin issues like rashes and itching.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Microneedling for hair loss may cause skin cancer.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Hair loss can occur when stomach cancer spreads to the scalp.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Anti-androgen therapy is crucial for treating cancer and hormone-related diseases, even with low testosterone levels.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

Wnt-activating drugs generally do not increase cancer risk.

Esomeprazole can cause hepatitis.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Erlotinib can cause hair loss and texture changes.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

A rare pituitary tumor in an 18-year-old male caused hormonal issues and vision loss, requiring surgery and further treatment.

Vorasidenib can cause unusual hair growth.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.